HCC Healthcare to List on Nasdaq via Merger with RF Acquisition Corp III

Key Facts

In a move highlighting the continued appeal of reverse mergers for international business expansion, HCC Healthcare announced it has entered into a definitive business combination agreement with RF Acquisition Corp III, a special purpose acquisition company (SPAC). According to reports, the transaction aims to transition HCC Healthcare into a publicly traded entity on the Nasdaq exchange. The company intends to use the listing to secure capital for accelerating its integrated medical and long-term care services across Asia.

This strategic step occurs as the Asian healthcare sector experiences significant growth, with market data indicating rising demand for specialized medical services due to aging populations. Comparing this to similar deals, experts suggest that a Nasdaq listing provides Asian firms with broader access to global institutional investors than local markets. RF Acquisition Corp III serves as the strategic partner in this process, where the merger structure will facilitate the liquidity required for HCC Healthcare's ambitious expansion plans.

Operationally, specific price data for the merged entity's shares is currently unavailable as the deal is in its early stages, per market data as of July 10, 2026. Investors should monitor regulatory approvals and shareholder meetings as upcoming catalysts for the merger's completion. Furthermore, the market is awaiting key economic data that could influence risk appetite in the growth sector, notably the ISM Services PMI in the United States scheduled for release shortly.